Dr. Rodrigo Rocamora Curriculum

Name: Rodrigo Rocamora

Position title: Director of Epilepsy Unit

Birth date: 26/08/1966

Citizenship: German

Gender: M

Office address: Passeig Maritim 25-29

Office telephone:

E-mail: rrocamora@parcdesalutmar.cat

1. Education / Training




Medical Degree (M.D.)

UNC, Facultad de Medicina; Mendoza, Argentina


Master in Neurology

Universidad Católica de Chile, Santiago, Chile


Visiting Fellow

Mayo Clinic. Department of Neurology. Minnesota, USA


Doctorate in Medicine (Ph.D)

University of Bonn. Bonn, Germany


Post-doctoral Training

University of Marburg. Marburg, Germany.

University of Freiburg. Freiburg, Germany.



2. Professional academic positions



Department & Institution


Neurology Resident

Department of Neurology. Universidad Católica de Chile


Doctoral Fellow

Department of Epileptology. University of Bonn, Germany


Associated Specialist

Department of Psychiatry and Department of Neurology. University of Marburg, Germany


Associated Specialist

Department of Neurosurgery. University of Freiburg, Germany


Director of the Sleep Centre

Department of Neurology. Hospital Ruber Internacional Madrid, Spain

2009 to date

Director of the Epilepsy Unit

Department of Neurology. Hospital del Mar, Barcelona, Spain.

2012 to 2014

Associated Professor

Medicine Faculty. Universitat Autónoma de Barcelona

2015 to date

Associated Professor

Biomedical Engineering. Universitat Pompeu Fabra

3. Honours and other professional activies

Dates (from-until)



Involvement in Institutional Activities:

Since 2009

Member of the Steering Committee of the Epilepsy Group. Sociedad Española de Neurología (SEN)

Since 2012

Member of the national network for epilepsy surgery (CSUR) as director Epilepsy Reference Centre in Hospital del Mar

Since 2014

Spanish representative in the European Commission`s Task Force for the organization of the European Reference Networks (ERNs)

Since 2015

Member of European Commission`s Task Force for the organization of ERNs

Since 2016

Member of E-pilepsy, the pan-European project of centres for epilepsy surgery

Since 2016

Member of EPI-Care, the European Reference Network (ERN) for Epilepsy


4. Publications (Selected from a total of 25)

  1. B. Kundermann, A. Thum, R. Rocamora, A. Haag, J. C. Krieg, and U. Hemmeter, "Comparison of polysomnographic variables and their relationship to cognitive impairment in patients with Alzheimer's disease and frontotemporal dementia," (in eng), J Psychiatr Res, vol. 45, no. 12, pp. 1585-92, Dec 2011. [IF: 4.664; citations: 12]
  2. M. Ley, A. Principe, J. Jiménez-Conde, and R. Rocamora, "Assessing long-term effects of eslicarbazepine acetate on lipid metabolism profile, sodium values and liver function tests," (in eng), Epilepsy Res, vol. 115, pp. 147-52, Sep 2015. [IF: 4.664; citations: 1]
  3. M. Ley, R. Vivanco, A. Massot, J. Jiménez, J. Roquer, and R. Rocamora, "[Safety study of long-term video-electroencephalogram monitoring]," (in spa), Neurologia, vol. 29, no. 1, pp. 21-6, 2014 Jan-Feb 2014. [IF: 3.957; citations: 1]
  4. A. Massot, R. Vivanco, A. Principe, J. Roquer, and R. Rocamora, "Post-authorisation study of eslicarbazepine as treatment for drug-resistant epilepsy: preliminary results," (in eng'spa), Neurologia, vol. 29, no. 2, pp. 94-101, Mar 2014. [IF: 1.381; citations: 17]
  5. J. Peltola, M. Holtkamp, R. Rocamora, P. Ryvlin, K. Sieradzan, and V. Villanueva, "Practical guidance and considerations for transitioning patients from oxcarbazepine or carbamazepine to eslicarbazepine acetate--Expert opinion," (in eng), Epilepsy Behav, vol. 50, pp. 46-9, Sep 2015. [IF: 2.257; citations: 3]
  6. R. Rocamora, "A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures," (in eng), Ther Adv Neurol Disord, vol. 8, no. 4, pp. 178-86, Jul 2015. [IF: 4; citations: 3]
  7. R. Rocamora, R. G. Andrzejak, J. Jiménez-Conde, and C. E. Elger, "Sleep modulation of epileptic activity in mesial and neocortical temporal lobe epilepsy: a study with depth and subdural electrodes," (in eng), Epilepsy Behav, vol. 28, no. 2, pp. 185-90, Aug 2013. [IF: 2.061; citations: 3]
  8. R. Rocamora et al., "Pilomotor seizures: an autonomic semiology of limbic encephalitis?," (in eng), Seizure, vol. 23, no. 8, pp. 670-3, Sep 2014. [IF: 1.822; citations: 15]
  9. R. Rocamora, A. Gil-Nagel, O. Franch, and A. Vela-Bueno, "Familial recurrent hypersomnia: two siblings with Kleine-Levin syndrome and menstrual-related hypersomnia," (in eng), J Child Neurol, vol. 25, no. 11, pp. 1408-10, Nov 2010. [IF: 1.668; citations: 5]
  10. R. Rocamora, M. Kurthen, L. Lickfett, J. Von Oertzen, and C. E. Elger, "Cardiac asystole in epilepsy: clinical and neurophysiologic features," (in eng), Epilepsia, vol. 44, no. 2, pp. 179-85, Feb 2003. [IF: 4.571; citations: 121]
  11. R. Rocamora, I. Mader, J. Zentner, and A. Schulze-Bonhage, "Epilepsy surgery in patients with multiple cerebral cavernous malformations," (in eng), Seizure, vol. 18, no. 4, pp. 241-5, May 2009. [IF: 2.233; citations: 20]
  12. R. Rocamora, P. Mendivil, and A. Schulze-Bonhage, "[Multiple supratentorial cavernomas and epilepsy surgery: case report]," (in spa), Neurocirugia (Astur), vol. 19, no. 3, pp. 257-63; discussion 263-6, Jun 2008. [IF: 0.277; citations: 2]
  13. R. Rocamora, J. C. Sánchez-Alvarez, and J. Salas-Puig, "The relationship between sleep and epilepsy," (in eng), Neurologist, vol. 14, no. 6 Suppl 1, pp. S35-43, Nov 2008. [IF: 2.083; citations: 4]
  14. R. Rocamora, K. Wagner, and A. Schulze-Bonhage, "Levetiracetam reduces frequency and duration of epileptic activity in patients with refractory primary generalized epilepsy," (in eng), Seizure, vol. 15, no. 6, pp. 428-33, Sep 2006. [IF: 2.179; citations: 21]
  15. P. J. Serrano-Castro, J. A. Mauri-Llerda, A. Garcia, R. Rocamora, A. Pardo-Merino, and P. Garcia-Garcia, "[Treatment adherence with levetiracetam: a non-interventionist retrospective observation-based study]," (in spa), Rev Neurol, vol. 62, no. 11, pp. 481-6, Jun 2016. [IF: 0.830; citations: -]
  16. M. Suárez-Piñera et al., "Perfusion SPECT, SISCOM and PET (18)F-FDG in the assessment of drug- refractory epilepsy patients candidates for epilepsy surgery," (in eng'spa), Rev Esp Med Nucl Imagen Mol, vol. 34, no. 6, pp. 350-7, 2015 Nov-Dec 2015. [IF: 0,983; citations: 1]
  17. V. Villanueva et al., "EPICON consensus: recommendations for proper management of switching to eslicarbazepine acetate in epilepsy," Neurologia, Jun 2016. [IF: 1.381; citations: 1]


Active External collaborations

  1. Prof. Gustavo Deco. Center of Brain and Cognition (UPF). Barcelona, Spain.
  2. Dr. Mara Dierssen. Centro de Regulación Genómica de Barcelona (PRBB). Barcelona, Spain.
  3. Prof. Andreas Schulze-Bonhage. Epilepsiezentrum Freiburg. University of Freiburg. Freiburg, Germany.
  4. Prof. Christian C-E. Elger. Klinik fuer Epileptologie. University of Bonn. Bonn, Germany.
  5. Prof. Andreas Becker. Institut für Neuropathologie. University of Bonn. Bonn, Germany.
  6. Prof. Philippe Kahane. Epilepsie et Malaises Neurologiques, Pavillon de Neurologie, Grenoble, France
  7. Prof. Olivier David. Grenoble Institut des Neurosciences (INSERM U836). Grenoble, France
  8. Prof. Philippe Rivlyn. Département des Neurosciences Cliniques (DNC) du CHUV. Lausanne, Swiss

Internal campaigns

  • Pla d'igualtat del PSMar
  • Hospitals sense fum
  • Hospitals sostenibles

Social networks

  • Twitter
  • Canal YouTube

© 2006 - 2018 Parc de Salut Mar · Legal notice | Cookie Policy | Accessibility